A Fasting‐Mimicking Diet Affects the Inflammatory Response Following Periodontal Treatment: A Multi‐centre Feasibility Randomised Controlled Pilot Trial
By Giuseppe Mainas, Elena Figuero, Marta Amigo Basilio, José Dopico, Florencia Julieta Gayo Morales, Antonio Magan‐Fernandez, Inmaculada Cabello, Guillermo Pardo Zamora, Josefina Guillén Sanchez, Jose Nart, Antonio Santos Alemany, Carlos Pereira Couto, Manlio Vinciguerra, Valter D. Longo, Mark Ide, Mariano Sanz, Luigi Nibali
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Periodontal specialists and practices that manage chronic periodontitis should be aware that a fasting-mimicking diet may modulate post-operative inflammation, potentially altering healing timelines and patient-reported outcomes after scaling/root-planing or surgical procedures.
Key points
- Multi-centre, feasibility RCT published in JCP (Aug 2026) tested a fasting-mimicking diet protocol in patients receiving non-surgical periodontal therapy.
- Primary endpoint was change in systemic inflammatory markers (CRP, IL-6) 7–14 days post-treatment; secondary endpoints included pocket depth reduction and patient comfort scores.
- Study does not yet alter guidelines; it signals a future adjunctive dietary intervention that could be discussed with medically-complex or inflammation-driven periodontitis patients.
- No commercial product or diet brand is endorsed; findings remain investigational and require larger efficacy trials before practice-level recommendations.
Who should care
Read the original on Journal of Clinical Periodontology
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Florida dental office remains closed amid patient death investigation
- ·Business
130+ DSO affiliations so far in 2026: State-by-state breakdown
- ·Regulatory
Congressman Introduces ORTHO Act for Teledentistry Safety
- ·Regulatory
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION